Modulating HMGB1 in COVID-19-associated inflammatory response

The project addresses urgent and clinically-relevant questions related to COVID-19, which causes in some patients life-threatening respiratory distress, septic shock and organ failures. Patients in intensive care units were found to have significantly higher levels of high mobility group box 1 (HMGB1) than patients with milder symptoms. HMGB1 is a protein normally found in the […]

Read More